Clinical Program
Relevant Publications

The term "anti-angiogenesis" was first proposed by Dr. Judah Folkman in 1971 following a series of brilliant observations around blood vessel proliferation. For decades, skeptics refused to accept this idea. In 2004, the FDA approved the first "pure play" anti-angiogenic compound. After over 30 years of persistence, Dr. Folkman is now recognized as the father of this important and emerging field of research.